German chemicals company to expand its reach into mRNA ingredient production
As the mRNA field has become more popular over the past several years, thanks in large part to the development of certain wildly popular Covid-19 vaccines, such as those from Moderna and BioNTech, more companies are looking to sink funds to accommodate its production.
German chemical company Wacker Chemie AG, which has been around since 1914, has been a mainstay in the production of silicone-based products and other medicinal chemicals, but now its biotech division is looking to sink nine figures into mRNA production.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.